Phase 3 Ovarian Cancer Trial, Recruiting (NCT04789694)

Phase 3 Ovarian Cancer Trial, Recruiting NCT04789694 Sponsor: Charles University, Czech Republic Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04789694 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have ovarian cancer (epithelial type) at an advanced stage (Stage III or IV), and your doctors have decided surgery is not the right first step — instead, you are due to have chemotherapy first, followed by surgery later
You have uterine (endometrial) cancer at an early stage (Stage I or II), your doctors have assessed you as "frail" using a specific health checklist, and you are suitable for hormone-based treatment

Who may not be able to join:

You are currently being treated for a second, separate cancer
Your treatment cannot be delayed even slightly, meaning there is no time to take part in the preparation programme before your surgery or treatment begins
You are physically unable to take part in a fitness/preparation programme, or you are unable to walk

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04789694

Sponsor: Charles University, Czech Republic

Phase: Phase 3

Status: Recruiting

Condition: Ovarian Cancer

More information: https://clinicaltrials.gov/study/NCT04789694

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have ovarian cancer (epithelial type) at an advanced stage (Stage III or IV), and your doctors have decided surgery is not the right first step — instead, you are due to have chemotherapy first, followed by surgery later
You have uterine (endometrial) cancer at an early stage (Stage I or II), your doctors have assessed you as "frail" using a specific health checklist, and you are suitable for hormone-based treatment

Who may not be able to join:

You are currently being treated for a second, separate cancer
Your treatment cannot be delayed even slightly, meaning there is no time to take part in the preparation programme before your surgery or treatment begins
You are physically unable to take part in a fitness/preparation programme, or you are unable to walk

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Charles University, Czech Republic

Registry

ClinicalTrials.gov

Start date

25 January 2021

Est. completion

30 June 2026

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Functional capacity changes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov